Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is ...
Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.
Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results